21.01.2025 • News

The Future of the Pharmaceutical World

Major and local pharma companies, CMOs, CDMOs, service and equipment providers gather at the Pharmaceutical Manufacturing and Packaging Congress (PHARMAP) to discuss new technologies and ongoing trends, as well as to establish business connections. The Congress takes place in Berlin, Germany, on April, 14-15, 2025.

PHARMAP is a networking event which annually brings over more than 300 leaders of the whole pharma industry. The participants can see innovations shown at the focus exhibition and enjoy thought-provoking discussions by the key players. Since 2021, the Congress has welcomed over 1,000 delegates and this year celebrates its 5th anniversary.

Annually, the Congress addresses challenges in the pharmaceutical sector, including manufacturing optimization and digitalization, supply chain disruptions, anti-counterfeiting measures and advancements in smart packaging. In 2025, the agenda expands to include discussions on pharmaceutical facility design and layout with Bayer presenting its innovative approaches in technology, design and execution. Besides those topics, the congress covers these themes:

  • Green initiatives and integration of sustainability;
  • Outsourcing and contract manufacturing;
  • Advancements in packaging technologies and labeling;
  • Pharma quality assurance.

The questions being brought up at the congress are valuable for the future of the pharmaceutical world, as well as the connections that companies form with each other to work together on projects that are advancing the industry. The sessions, round tables, coffee breaks and anniversary gala dinner - all activities are great for collaboration.

Join PHARMAP 2025 by visiting the website: https://sh.bgs.group/26i

Company

BGS Group



Netherlands

Company contact







Interview

Driving Sustainability Through Collaboration
Building Green Practices Across the Chemical Supply Chain

Driving Sustainability Through Collaboration

Together for Sustainability (TfS) is a pioneering, member-led initiative working to accelerate sustainable and resilient chemical supply chains. TfS President Jennifer Jewson discusses the origins of TfS, its evolving goals, its present-day challenges, and the initiative’s enduring impact and outlook for the future.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read